VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat ...

Inhaled sevoflurane sedation in patients with moderate to severe acute respiratory distress syndrome results in fewer ...

Inhaled anesthetic use was popularized during the COVID-19 sedative shortages, and interest persisted due to an association ...

Methods: We used the Medline database to select studies with the key words “acute lung injury,” “ARDS,” “acute respiratory ... Importantly, ARDS is a syndrome and not an illness, and ...

The following is a summary of “Subphenotyping prone position responders with machine learning,” published in the March 2025 issue of Critical Care by Fosset et al. Researchers conducted a retrospectiv ...

Signs of acute respiratory failure include dizziness, shortness of breath, confusion, drowsiness, and a bluish discoloration of your lips, skin, or extremities. It can be life threatening and ...

HCoV-HKU1, which spreads through respiratory droplets, is less severe than SARS or COVID-19. Experts suggested preventive ...

Latest findings on Healios K.K.’s stem cell therapy to treat acute respiratory distress syndrome (ARDS), coined Multistem ...

Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...

A poster describing the ongoing Acute Respiratory Distress Syndrome (ARDS) clinical trial of gelsolin will also be presented. Both presentations will take place on March 19. MedInvest Biotech & Pharma ...